Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Firefly Neuroscience (AIFF) Return on Assets (2016 - 2025)

Historic Return on Assets for Firefly Neuroscience (AIFF) over the last 13 years, with Q3 2025 value amounting to 1.55%.

  • Firefly Neuroscience's Return on Assets fell 5500.0% to 1.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.55%, marking a year-over-year decrease of 5500.0%. This contributed to the annual value of 2.89% for FY2024, which is 28300.0% down from last year.
  • Per Firefly Neuroscience's latest filing, its Return on Assets stood at 1.55% for Q3 2025, which was down 5500.0% from 1.67% recorded in Q2 2025.
  • Firefly Neuroscience's 5-year Return on Assets high stood at 0.19% for Q1 2021, and its period low was 2.48% during Q1 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.93% (2022), whereas its average is 0.84%.
  • Within the past 5 years, the most significant YoY rise in Firefly Neuroscience's Return on Assets was 8500bps (2023), while the steepest drop was -17600bps (2023).
  • Over the past 5 years, Firefly Neuroscience's Return on Assets (Quarter) stood at 0.07% in 2021, then plummeted by -1249bps to 0.93% in 2022, then surged by 91bps to 0.09% in 2023, then plummeted by -1816bps to 1.63% in 2024, then increased by 5bps to 1.55% in 2025.
  • Its Return on Assets stands at 1.55% for Q3 2025, versus 1.67% for Q2 2025 and 2.48% for Q1 2025.